Common Healthcare Compliance Questions
Compliance Due Diligence: A Cost or a Value Driver? (with Amanda Doran)
Amanda Doran of Waud Capital Partners on compliance due diligence in healthcare M&A, defending value on the sell side, and hiring the right compliance leader.
Corporate Integrity Agreement: Preferred Partner or Liability? (with Jillian Marcus)
Jillian Marcus, Chief Compliance Officer at Envision Healthcare, joins Ross Ronan to show how a Corporate Integrity Agreement can make you a preferred partner with the OIG, why compliance should report to the CEO and board, and how a strong program turns into real enterprise value.
The Investment Deep Dive, Part 3: How Do You Scale Compliance As You Grow?
Ross Ronan on scaling healthcare compliance investment as you grow: what to budget, how it scales, and getting exit-ready before a sale or diligence.
The Investment Deep Dive, Part 2: What Does Compliance Investment Actually Buy You?
Ross Ronan on what healthcare compliance investment looks like in practice: the boardroom budget talk, the PE sponsor view, and why the right officer comes first.
The Investment Deep Dive, Part 1: How Much Should You Spend on Healthcare Compliance?
A basic compliance program for a healthcare startup costs around $50,000 per year. With dedicated compliance leadership, that number rises to $150,000 to $175,000 or more. In this episode, Ross Ronan, JD, BSN, CPCO, CHC, CCEP, CMPE, walks founders and CEOs through a realistic first-year budget, a phased approach for bootstrapped organizations, and the 1% of revenue rule that keeps your program right-sized as you grow.
Is Your Healthcare Platform Too Small to Need a Compliance Program?
“Too small for compliance" is one of the most expensive assumptions in healthcare. Here is what it really costs, and how to build a program that protects what you are building.
How a Compliance Program Raises Your Valuation (with Jerry Chang)
Valuation expert Jerry Chang of Stout joins Ross Ronan on The Compliance Advantage to explain how a strong healthcare compliance program lowers perceived risk, protects deal value, and raises your multiple at exit. Real diligence stories included.
The Day After You Close, the Compliance Bar Goes Up (with Baxter Lee)
Clearwater President Baxter Lee joins Ross Ronan on The Compliance Advantage to explain why compliance and security must scale with healthcare M&A growth. A diligence report on a shelf is not protection. Learn how to build a program that drives enterprise value.
The Regulatory Advantage: How Innovators Win with Dr. Adam Brown
Dr. Adam Brown of ABIG Health on why a real compliance program is what lets healthcare innovators sell, pass due diligence, and protect the value of a deal.
Is Your Healthcare Startup Building on the Right Foundation?
A founder ran his healthcare organization for two years before anyone said the word compliance. Here are the five basics that keep that gap small and let you grow clean.
Compliance, Capital, and the Deal: What Investors Really Want with James Carey
Many private equity firms walk away from healthcare companies over reimbursement risk before they ever get to the upside. James Carey joins Ross Ronan to explain what investors really want, and how transparency on coding and payer mix turns compliance into the advantage that gets a deal done.
Healthcare Compliance for Startups, Part 3: What You Gain, and How to Protect Your Investment
Many founders think their healthcare company is too small to need a compliance program. Ross Ronan, JD, BSN, CPCO, CHC, CCEP, CMPE, explains why that assumption is the expensive one, and how compliance built early protects your profits, your partnerships, and the investment everyone has made in the company.
How Much Should You Really Invest in a Compliance Program?
What does a healthcare compliance program actually cost? Real investment ranges start at $150,000 for smaller organizations and scale up from there. We share a simple framework for matching your compliance budget to your payor mix and growth stage.
Healthcare Compliance for Startups, Part 2: What to Budget, How to Phase, and When to Scale
A basic compliance program for a healthcare startup costs around $50,000 per year. With dedicated compliance leadership, that number rises to $150,000 to $175,000 or more. In this episode, Ross Ronan, JD, BSN, CPCO, CHC, CCEP, CMPE, walks founders and CEOs through a realistic first-year budget, a phased approach for bootstrapped organizations, and the 1% of revenue rule that keeps your program right-sized as you grow.
Healthcare Compliance for Startups, Part 1: When to Start, What to Build, and How to Scale
When should a healthcare startup build a compliance program? Ideally before the first patient. In Part 1 of this series, Ross Ronan walks healthcare leaders through the five compliance essentials every new organization needs.
What Does It Actually Cost When You Skip Compliance Investment?
What does smart compliance investment actually protect? In this post, we walk through the four areas where early investment pays off: keeping the revenue you've earned, staying ahead of cleanup work, freeing your leadership team to lead, and building the kind of reputation that attracts better partners.
What Are the Three Returns That Make Compliance Worth the Investment?
Healthcare compliance investment delivers three measurable returns: Profit Protection (keeping revenue you've earned), Preferred Partner Status (opening doors to partnerships and better valuations), and Patient Trust Equity (building sustainable competitive advantage through patient loyalty). Together, these "Three P's" transform compliance from a cost center into a growth enabler for healthcare organizations.
What's Really Behind "We Don't Have Budget for Compliance"?
"We don't have budget for compliance" is something every healthcare CEO has heard—or said. But what does that sentence actually mean? In this post, we break down the psychology behind compliance budget resistance and reveal the hidden reality: you're already spending the money, just in ways you don't see yet. Discover the reframing exercise that helps healthcare leaders understand what's really at risk and why the executives who sleep well at night stopped debating this investment years ago.